協和キリンJP:4151損益計算書

時価総額
¥1.48兆
PER
19.6倍
医療用医薬品の製造および販売を手がける企業で、主要な事業として医薬品の開発と提供を行う。
2011/122012/122013/122014/122015/122016/122017/122018/122019/122020/122021/122022/122023/122024/122025/12
売上高343,722333,158340,611333,446364,316343,019353,380346,531305,820318,352352,246398,371442,233495,558496,826
売上成長率(%)-
売上原価---127,542138,922134,52662,66862,76479,62080,44087,84986,915111,207132,611127,934
売上総利益---205,904225,393208,493147,948152,390226,200237,912264,398311,455331,026362,947368,892
売上総利益率(%)---
営業利益率 (%)---
営業費用---169,731181,628176,854109,314110,160117,316126,610145,608166,185163,078167,537165,434
営業利益---36,17343,76531,63838,63542,23050,02948,66924,80240,63453,427-4,62260,047
経常(税引前)利益46,75449,00149,50229,51139,20326,39755,84973,43844,49252,26360,05067,57297,24683,45356,925
経常(税引前)利益率(%)13.614.714.58.910.87.715.821.214.516.417172216.811.5
法人税等合計---11,34611,62511,6198,87314,3976,8185,2367,70314,00016,05823,58320,182
実効税率(%)---
純利益25,60824,19930,07815,89829,77418,66942,89954,41467,08447,02752,34753,57381,18859,87032,439
一株あたり利益45.1644.1254.9529.0554.434.1278.3899.4124.5787.5697.4399.68151.03113.0661.97
希薄化後一株あたり利益45.1444.154.9129.0254.3634.0848.187.34124.4687.597.3999.66151.01113.06128.07
配当性向(%)--------
一株あたり配当金--------42444651565862